What is Tissue-Grown?
Founded in 1986, Tissue-Grown Corporation operates at the intersection of advanced cell genetics and commercial horticulture. The company specializes in the mass production of disease-indexed fruit and nut tree rootstocks, including critical global commodities such as pistachios, coffee, and walnuts. By integrating sophisticated micropropagation techniques with rigorous physiological research, the firm provides a scalable solution to the challenges of modern orchard management and crop resilience.
The organization maintains a state-of-the-art facility that serves as the nexus for its research and development efforts. Their focus on sustainable propagation practices allows them to meet the high-volume demands of the agricultural sector while maintaining strict genetic integrity. As a key player in the horticultural supply chain, Tissue-Grown Corporation is uniquely positioned to address the increasing global demand for high-yield, disease-resistant plant materials.
How much funding has Tissue-Grown raised?
Tissue-Grown has raised a total of $2M across 3 funding rounds:
Debt
$350K
Debt
$600K
Debt
$1.1M
Debt (2020): $350K with participation from PPP
Debt (2021): $600K led by PPP
Debt (2024): $1.1M, investors not publicly disclosed
Key Investors in Tissue-Grown
PPP
Public-Private Partnership
Undisclosed Investor
A strategic partner participating in the most recent financing round to facilitate long-term growth and market expansion.
What's next for Tissue-Grown?
With the successful closure of its most recent financing round, Tissue-Grown Corporation is poised to accelerate its strategic expansion initiatives. The capital will likely be deployed toward enhancing production capacity and deepening its research capabilities in plant genetics. By fostering new partnerships and scaling its high-volume propagation projects, the company aims to solidify its dominance in the rootstock market.
Looking ahead, the firm is expected to prioritize the integration of automated propagation technologies to further optimize efficiency. This strategic focus on operational excellence, combined with a commitment to sustainable agricultural practices, positions Tissue-Grown Corporation to capitalize on the growing need for resilient, high-performance horticultural crops in an increasingly volatile climate.
